Evidence map›Paper›PMID 23012361›Full record

ArticleThe Journal of biological chemistry2012

Activity, specificity, and probe design for the smallpox virus protease K7L.

Alexander E Aleshin, Marcin Drag, Naran Gombosuren, Ge Wei, Jowita Mikolajczyk, Arnold C Satterthwait, Alex Y Strongin, Robert C Liddington, Guy S Salvesen

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Targeting the I7L Protease: A Rational Design for Anti-Monkeypox Drugs?International journal of molecular sciences · 2023
    Article
  5. Viral proteases as therapeutic targets.Molecular aspects of medicine · 2022
    Review
  6. Review
  7. SARS-CoV-2 MNature chemical biology · 2021
    Article
  8. Article
  9. Capsid protein structure, self-assembly, and processing reveal morphogenesis of the marine virophage mavirus.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alexander E AleshinProgram in Apoptosis and Cell Death Research, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.
Marcin Drag
Naran Gombosuren
Ge Wei
Jowita Mikolajczyk
Arnold C Satterthwait
Alex Y Strongin
Robert C Liddington
Guy S Salvesen
Sanford Burnham Prebys Medical Discovery Institute · US

Funding

Structure-based Drug Design for Smallpox TherapyU01AI061139 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI STRONGIN, ALEX Y · 2004 to 2008
$8.8M
NIAID NIH HHS AI061139NIAID NIH HHS U01 AI061139
6 · The paper itself

Abstract

The K7L gene product of the smallpox virus is a protease implicated in the maturation of viral proteins. K7L belongs to protease Clan CE, which includes distantly related cysteine proteases from eukaryotes, pathogenic bacteria, and viruses. Here, we describe its recombinant high level expression, biochemical mechanism, substrate preference, and regulation. Earlier studies inferred that the orthologous I7L vaccinia protease cleaves at an AG-X motif in six viral proteins. Our data for K7L suggest that the AG-X motif is necessary but not sufficient for optimal cleavage activity. Thus, K7L requires peptides extended into the P7 and P8 positions for efficient substrate cleavage. Catalytic activity of K7L is substantially enhanced by homodimerization, by the substrate protein P25K as well as by glycerol. RNA and DNA also enhance cleavage of the P25K protein but not of synthetic peptides, suggesting that nucleic acids augment the interaction of K7L with its protein substrate. Library-based peptide preference analyses enabled us to design an activity-based probe that covalently and selectively labels K7L in lysates of transfected and infected cells. Our study thus provides proof-of-concept for the design of inhibitors and probes that may contribute both to a better understanding of the role of K7L in the virus life cycle and the design of novel anti-virals.

Indexed as

Peptide LibraryAmino Acid MotifsAnimalsAntiviral AgentsCell LineCricetinaeDrug DesignMolecular ProbesPeptide HydrolasesProtease InhibitorsSmallpoxVariola virusViral ProteinsAntiviral AgentsMolecular ProbesPeptide HydrolasesPeptide LibraryProtease InhibitorsViral Proteins

Identifiers

PMID23012361
PMCPMC3501048
OpenAlexW2013924665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.